Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma.
Taniguchi E, Nishijo K, McCleish AT, Michalek JE, Grayson MH, Infante AJ, Abboud HE, Legallo RD, Qualman SJ, Rubin BP, Keller C. Taniguchi E, et al. Among authors: legallo rd. Oncogene. 2008 Nov 20;27(51):6550-60. doi: 10.1038/onc.2008.255. Epub 2008 Aug 4. Oncogene. 2008. PMID: 18679424 Free PMC article.
Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.
Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, Prajapati SI, Gelfond JA, Chisholm GB, Michalek JE, Aronow BJ, Barr FG, Randall RL, Ladanyi M, Qualman SJ, Rubin BP, LeGallo RD, Wang C, Khan J, Keller C. Nishijo K, et al. Among authors: legallo rd. Cancer Res. 2009 Apr 1;69(7):2902-11. doi: 10.1158/0008-5472.CAN-08-3723. Cancer Res. 2009. PMID: 19339268 Free PMC article.
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma.
Abraham J, Prajapati SI, Nishijo K, Schaffer BS, Taniguchi E, Kilcoyne A, McCleish AT, Nelon LD, Giles FG, Efstratiadis A, LeGallo RD, Nowak BM, Rubin BP, Malempati S, Keller C. Abraham J, et al. Among authors: legallo rd. Mol Cancer Ther. 2011 Apr;10(4):697-707. doi: 10.1158/1535-7163.MCT-10-0695. Epub 2011 Mar 29. Mol Cancer Ther. 2011. PMID: 21447712 Free PMC article.
Lineage of origin in rhabdomyosarcoma informs pharmacological response.
Abraham J, Nuñez-Álvarez Y, Hettmer S, Carrió E, Chen HI, Nishijo K, Huang ET, Prajapati SI, Walker RL, Davis S, Rebeles J, Wiebush H, McCleish AT, Hampton ST, Bjornson CR, Brack AS, Wagers AJ, Rando TA, Capecchi MR, Marini FC, Ehler BR, Zarzabal LA, Goros MW, Michalek JE, Meltzer PS, Langenau DM, LeGallo RD, Mansoor A, Chen Y, Suelves M, Rubin BP, Keller C. Abraham J, et al. Among authors: legallo rd. Genes Dev. 2014 Jul 15;28(14):1578-91. doi: 10.1101/gad.238733.114. Genes Dev. 2014. PMID: 25030697 Free PMC article.
PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM, Atkins KA, LeGallo RD. Sullivan LM, et al. Among authors: legallo rd. Am J Surg Pathol. 2009 May;33(5):775-80. doi: 10.1097/PAS.0b013e318191614f. Am J Surg Pathol. 2009. PMID: 19145202
From slide sets to sound bites: teaching and learning pathology in the digital age.
Mills AM, Meyers-Needham M, LeGallo RD, Boyd JC, Cathro HP, Haverstick DM, La Fortune KA, Mills SE, Moskaluk CA, Stelow EB, Poulter MD, Stoler MH, Wick MR, Atkins KA. Mills AM, et al. Among authors: legallo rd. J Am Soc Cytopathol. 2014 Jul-Aug;3(4):183-187. doi: 10.1016/j.jasc.2014.03.003. Epub 2014 Mar 22. J Am Soc Cytopathol. 2014. PMID: 31051684
Recruiting the future of pathology.
LeGallo RD, Atkins KA. LeGallo RD, et al. Cancer Cytopathol. 2022 Aug;130(8):576-578. doi: 10.1002/cncy.22606. Epub 2022 Jun 9. Cancer Cytopathol. 2022. PMID: 35679145 Free PMC article. No abstract available.
41 results